|
× |
|
Comparison of 2 Treatment Strategies for Depressed Inpatients: Imipramine and Lithium Addition or Mirtazapine and Lithium Addition PDF |
$40.00 |
|
$40.00 |
|
× |
|
Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Preliminary Study of Risperidone in the Treatment of Posttraumatic Stress Disorder Related to Childhood Abuse in Women PDF |
$40.00 |
|
$40.00 |
|
× |
|
Exposure to Second-Generation Antipsychotics and Risk of Type 2 Diabetes Mellitus in Adolescents and Young Adults: A Nationwide Study in Taiwan PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine: A Secondary Analysis of 4 Studies in Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Is Flunarizine a Long-Acting Oral Atypical Antipsychotic? A Randomized Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Differential Prediction of First Clinical Response to Serotonergic and Noradrenergic Antidepressants Using the Loudness Dependence of Auditory Evoked Potentials in Patients With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Rapid Detoxification in an Adult With Benzodiazepine Dependence With the Aid of an Antiepileptic PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Case of Wernicke-Korsakoff Syndrome Treated 1 Year After the Onset of Symptoms PDF |
$40.00 |
|
$40.00 |
|
× |
|
Association of Small Life Events With Self Reports of Tic Severity in Pediatric and Adult Tic Disorder Patients: A Prospective Longitudinal Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Longitudinal Trajectories of Psychotic-Like Experiences and Their Relationship to Emergent Mental Disorders Among Adolescents: A 3-Year Cohort Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder PDF |
$40.00 |
|
$40.00 |
|
|